Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)

Author:

Apostolidis Apostolos1,Averbeck Marcio Augusto2,Sahai Arun3,Rahnama'i Mohammad Sajjad4,Anding Ralf5,Robinson Dudley6,Gravas Stavros7,Dmochowski Roger8

Affiliation:

1. 2nd Department of Urology; Aristotle University of Thessaloniki; Thessaloniki Greece

2. Department of Urology; Moinhos de Vento Hospital; Porto Alegre Brazil

3. Department of Urology; Guy's and St.Thomas’ Hospitals; London UK

4. Department of Urology; Maastricht University; Maastricht The Netherlands

5. Department of Neurourology; University Hospital Bonn; Bonn Germany

6. Department of Urogynaecology; King's College Hospital; NHS Foundation Trust; London UK

7. Department of Urology; University of Thessaly; Larissa Greece

8. Department of Urology; Vanderbilt University; Nashville Tennesse

Funder

Pfizer

Coloplast

ASTELLAS

“Education & Lifelong Learning” Operational Programme

Galenica

Allergan

Astellas Pharma US

Pierre-Fabre Medicament

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3